ONA interview: Coordinating with specialty pharmacies
ONA talked to an oncology nurse with Walgreens’ cycle management program about how this novel program helps patients and clinicians better manage outpatient oral chemotherapy.
ONA talked to an oncology nurse with Walgreens’ cycle management program about how this novel program helps patients and clinicians better manage outpatient oral chemotherapy.
The CD20 antagonist is a potentially effective preventive and treatment for this common adverse effect of hematopoietic stem cell transplantation.
Administration, safety, and efficacy are similar in both agents. However, the frequency of administration makes a significant difference for patients.
VADs enable long-term IV therapy; however, the devices and their use pose a unique set of challenges for nurses.
A form of psychotherapy that is intended to relieve distress for dying patients and their families showed great effectiveness in a recent study.
The FDA has approved a portable therapeutic system that can be used at home by adults who have glioblastoma that has recurred or progressed following chemotherapy and radiotherapy.
Standardized posthospitalization care education administered through an Oncology CarePartner Program that addressed the patient’s physical and emotional needs was found to improve caregivers’ overall well-being, but had no impact on the time spent on caregiving or difficulty with caregiving tasks. That’s the result of a study presented at the Oncology Nursing Society 36th Annual Congress.
The CDC and the Healthcare Infection Control Practices Advisory Committee have released new guidelines to help eliminate bloodstream infections associated with intravenous catheters.
Where patients spend their final days has an impact on the quality of life at the end of their life, as well as their caregivers’ mental health after their death.
Caregivers are an essential part of patient care. Attentiveness to their concerns is an important part of caring for the patient with cancer.